Key Releases are ad hoc announcements pursuant to SIX Swiss Exchange Article 53 Listing Rules.
February 2023
January 2023
-
Featured NewsNovartis provides update on Phase III STAND trial assessing crizanlizumab
-
Featured NewsWorld Economic Forum 2023 -
Featured NewsNovartis shares strategy insights and highlights key pipeline catalysts at JP Morgan Healthcare Conference 2023
-
Featured NewsZolgensma Global Managed Access Program in 2023
